Pharmagen ApS: Financial statements 2017
CVR: 36687193
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 356,650 and a net result of DKK 269,922 compared with DKK 295,924 the year before. That is a decrease of 10.1% compared with the year before. Equity in the 2017 report amounted to DKK 619,019. The solvency ratio was 36%.
- Gross Profit
- DKK 356,650
- Profit/Loss
- DKK 269,922
- Equity
- DKK 619,019
- Total Assets
- DKK 1,719,776
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 357 t. | 270 t. | 619 t. | - |
| 2016 | - | 397 t. | 296 t. | 349 t. | - |
Official annual report
Keep an eye on Pharmagen ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Pharmagen ApS has published its annual report for 2016. Gross profit came to DKK 396,649, and the net result was DKK 295,924.
About Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.